Stock ABVX ABIVAX
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Abivax

Equities

ABVX

FR0012333284

Real-time Euronext Paris
Other stock markets
 08:30:56 29/04/2024 BST 		5-day change 1st Jan Change
14.84 EUR +0.13% Intraday chart for Abivax +3.06% +51.12%
04-11 Morgan Stanley Adjusts Price Target on Abivax to $16 From $15, Maintains Equalweight Rating MT
04-08 Transcript : ABIVAX Société Anonyme, 2023 Earnings Call, Apr 08, 2024

Evolution of the average Target Price on Abivax

Price target over the last 5 years

History of analyst recommendation changes

aa507024034.yngOaTeQAP_0-1WbV9ackyNR2fQoSKa4U2760BHiaiM.lRVmX2Xka76WijKpNpWx1Hk1o7NCefyLCgDKoGXUCEamFzoPWcFRurqjGA~e00ef23f3ef2d92915a0d2fcc750f394

Analyst Recommendations on Abivax

Morgan Stanley Adjusts Price Target on Abivax to $16 From $15, Maintains Equalweight Rating MT
Abivax: in green, broker in support CF
ABIVAX : Oddo BHF maintains its outperform rating CF
Valneva: up sharply after positive analysis CF
ABIVAX : Portzamparc downgrades its recommendation CF
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
14.82 EUR
Average target price
35.74 EUR
Spread / Average Target
+141.16%
High Price Target
65 EUR
Spread / Highest target
+338.60%
Low Price Target
17.7 EUR
Spread / Lowest Target
+19.43%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Abivax

Morgan Stanley

Ratings for Abivax

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ABVX Stock
  4. Consensus Abivax